Neurokine Pharmaceuticals Inc. NEUKF Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Neurokine Pharmaceuticals Inc. NEUKF Company Overview 

Stock Message Board http://investorshangout.com/search?q=NEUKF&am...mp;yt1=Go!

Neurokine Pharmaceuticals Inc. NEUKF Current Price and Quotes
Last Price 0.015
Previous Close 0.015 Open N/A
Daily Range N/A - N/A 52wk Range 0.02 - N/A
Volume 0 Dividend N/A
Average Vol (3m) 5,757 Yield N/A
Neurokine Pharmaceuticals Inc. NEUKF
Company Information

1275 West 6th Avenue
Vancouver, BC V6H 1A6
Canada

Website: http://www.neurokine.com
Phone: 604-805-7783
Email: info@neurokine.com

Neurokine Pharmaceuticals Inc. NEUKF
Neurokine Pharmaceuticals Inc. focuses on development of new use for existing marketed products for diseases mediated by acute and chronic inflammatory reactions. The company is developing proprietary encapsulation technology to allow better blood brain barrier penetration to initiate or enhance therapeutic effects of anti-inflammatory drugs in the treatment of neurodegenerative diseases.

Neurokine Pharmaceuticals Inc. NEUKF
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jul 31, 2013 10-Q
CIK 0001464165
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Feb 24, 2011
Incorporated In: British Columbia, Canada
Year of Inc. 2007
Employees 3 a/o Feb 24, 2011
Company Officers/Contacts

Hamid Doroudian President, CEO, Secretary
Moira Ong CFO, Principal Acct. Officer
Company Directors

Ahmad Doroudian Chairman
Richard Azani
Service Providers

Auditor/Accountant
Saturna Group Chartered Accountants LLP
1066 West Hastings Street
Suite 1250
Vancouver, BC, V6E3X2
Canada

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Neurokine Pharmaceuticals Inc. NEUKF
NEUKF Security Details

Share Structure

Market Value1 $536,506 a/o Sep 20, 2013
Shares Outstanding 35,767,073 a/o Sep 16, 2013
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record 38 a/o May 16, 2013
Short Selling Data

Short Interest 0 (-100%)
Sep 15, 2011
Significant Failures to Deliver  No
Transfer Agent(s)



Neurokine Pharmaceuticals Inc. NEUKF Recent News

Neurokine Pharmaceuticals Inc. NEUKF Financials
Period Ending Jan 31, 2013 Jan 31, 2012 Jan 31, 2011 Jan 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development - 58 - 2
Sales, General and Admin. 89 300 142 110
Non-Recurring Items - - - -
Other - - - -
Operating Income (89) (361) (144) (113)
Income From Continuing Operations

Add'l Income/Expense Items 456 2,139 (2,881) (1)
Earnings Before Interest and Tax 366 1,781 (3,023) (113)
Interest Expense 24 367 - -
Earnings Before Tax 342 1,414 (3,023) (113)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 342 1,414 (3,023) (113)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 342 1,414 (3,023) (113)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 342 1,414 (3,023) (113)

NEUKF Neurokine Pharmaceuticals Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=NEUKF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NEUKF/quote
Stock Chart http://www.otcmarkets.com/stock/NEUKF/chart
Company Info http://www.otcmarkets.com/stock/NEUKF/company-info
Recent News http://www.otcmarkets.com/stock/NEUKF/news
Financials http://www.otcmarkets.com/stock/NEUKF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NEUKF/filings
Short Sales http://www.otcmarkets.com/stock/NEUKF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NEUKF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NEUKF/research
Summary http://finance.yahoo.com/q?s=NEUKF
Historical Prices http://finance.yahoo.com/q/hp?s=NEUKF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NEUKF
Basic Chart http://finance.yahoo.com/q/bc?s=NEUKF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NEUKF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NEUKF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NEUKF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NEUKF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NEUKF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NEUKF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NEUKF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NEUKF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NEUKF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NEUKF
Balance Sheet http://finance.yahoo.com/q/bs?s=NEUKF
Cash Flow http://finance.yahoo.com/q/cf?s=NEUKF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NEUKF
Market Watch http://www.marketwatch.com/investing/stock/NEUKF
Bloomberg http://www.bloomberg.com/quote/NEUKF:US
Morningstar http://quotes.morningstar.com/stock/s?t=NEUKF
Bussinessweek http://investing.businessweek.com/research/st...cker=NEUKF
Barchart http://www.barchart.com/quotes/stocks/NEUKF
OTC Short Report http://otcshortreport.com/index.php?index=NEUKF
Investopedia http://www.investopedia.com/markets/stocks/NEUKF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 392

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 404

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 346

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 181

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 103

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 337

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Prudent Growth Partners Expands with Castle Shops Acquisition

Updated Category News Views 174

Prudent Growth Partners Enhances Retail Portfolio Prudent Growth Partners, LLC, a well-established private equity real estate firm, has recently made a significant leap forward by acquiring Castle Shops for $5.4 million. This 37,309 square foot retail center is situated in a bustling area, presenting exciting opportunities for growth and development. Strategic Location of...

Continue Reading
TOYO Co., Ltd Unveils Ambitious Solar Manufacturing Project

Updated Category News Views 220

TOYO Co., Ltd Unveils Plans for Solar Manufacturing Facility TOYO Co., Ltd (NASDAQ: TOYO), a leading company specializing in solar solutions, is thrilled to reveal its plans for a cutting-edge solar cell manufacturing facility. This new plant is expected to have an impressive annual capacity of 2 gigawatts (GW), reflecting TOYO's commitment to advancing renewable energy...

Continue Reading
Future Trends in the AI Semiconductor Ecosystem Explained

Updated Category News Views 331

Understanding the AI Semiconductor Ecosystem The AI semiconductor ecosystem is evolving rapidly, a movement driven largely by the increasing need for computational power essential for artificial intelligence advancements. This sector has reached a pivotal point where the demand for AI-powered solutions, especially large language models, significantly exceeds current chip...

Continue Reading
Broadwind Set to Release Year-End 2024 Results Soon

Updated Category News Views 199

Broadwind's Upcoming Financial Results Announcement Broadwind (Nasdaq: BWEN), a leading precision manufacturer known for its specialized components and solutions, has exciting news. They are set to announce their financial results for the fourth quarter and full year of 2024. This important update will occur before the market begins on a scheduled day. Conference Call...

Continue Reading
Snowflake Stock Earnings Rollercoaster: The Good and Bad

Updated Category News Views 305

Rocky Road for Snowflake: Earnings Highlights Turn the lights on, folks. Right when you thought Snowflake was ready to soar, the stock pulled some classic market gymnastics. This company just reported a fourth-quarter revenue of $1.28 billion, which isn't just pocket change; that’s $50 million over what the analysts were slinging around, estimating a mere $1.26 billion...

Continue Reading